Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade

Tsz Tung Kwong, Chi Hang Wong, Jing Ying Zhou, Alfred S.l. Cheng, Joseph J.�y. Sung, Anthony W.h. Chan, Stephen L. ChanJHEP 2020 · DOI

Abstract

Our findings suggest that some chemotherapies may impair the anti-tumor efficacy of immunotherapy. Further studies are required to uncover the specific effects of different chemotherapies on the immunological profile of tumors. This data will be critical for the rational design of combination immunotherapy strategies for patients with hepatocellular carcinoma.
BibTeX
@inproceedings{kwong2020chemotherapy,
  author = {Tsz Tung Kwong and Chi Hang Wong and Jing Ying Zhou and Alfred S.L. Cheng and Joseph J.�Y. Sung and Anthony W.H. Chan and Stephen L. Chan},
  title = {{Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade}},
  booktitle = {JHEP},
  year = {2020},
  doi = {10.1016/j.jhepr.2020.100224},
}

Loading related content...

Figure